Gossamer Bio Inc (Gossamer) is a clinical-stage biopharmaceutical company that discovers, acquires, develops and commercializes therapeutics in the disease areas of immunology, inflammation and oncology. The company’s product portfolio includes GB002, for pulmonary arterial hypertension, GB5121 for adult patients with relapsed/refractory CNS lymphoma and GB7208 for multiple sclerosis. Gossamer operates un the US and Ireland. Gossamer is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
3013 Science Park Rd, San Diego, California, 92121-1101
Website
www.gossamerbio.com
Telephone
1 858 9220718
No of Employees
135
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
GOSS (NASD)
EPS
XYZ
Net Income (2022)
XYZ
21.6%
(2022 vs 2021)
Market Cap*
$159.8M
* As of and is in US$
Gossamer Bio Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline Products |
GB002: Pulmonary Arterial Hypertension |
GB5121: Primary CNS Lymphoma |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Gossamer Bio Inc | Kiniksa Pharmaceuticals Ltd | Deciphera Pharmaceuticals Inc | Sutro Biopharma Inc | Arcus Biosciences Inc |
---|---|---|---|---|---|
Headquarters | United States of America | Bermuda | United States of America | United States of America | United States of America |
City | San Diego | Hamilton | Waltham | South San Francisco | Hayward |
State/Province | California | - | Massachusetts | California | California |
No. of Employees | 135 | 297 | 355 | 302 | 577 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Faheem Hasnain | President; Chairman; Chief Executive Officer | Executive Board | 2020 | 64 |
Bryan Giraudo | Chief Operating Officer; Chief Financial Officer | Senior Management | 2021 | 47 |
Richard Aranda | Chief Medical Officer | Senior Management | 2021 | 63 |
Laura Carter | Chief Scientific Officer | Senior Management | 2021 | 56 |
Rainer Zimmermann, MD | Vice President - Medical Affairs | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer